Research News

High-dose Vitamin C Helps Ovarian Cancer Patients

(February 21, 2014) Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some cancer patients. By evaluating the therapy... 

Regular Aspirin Use May Reduce Ovarian Cancer Risk

(February 10, 2014) Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI).  However, further research is needed before clinical recommendations can be made. The study, which was conducted as part... 

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited Predisposition

(January 31, 2014)  A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis.  Most women in the study would have been unaware... 

OCRF Research Finds New Factor in Ovarian Cancer Development

Yin Wang, PhD (Mayo Clinic)   (January 30, 2014)  OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in Molecular Cancer Research, also found that Auranofin,  a small molecular compound,... 

2014 Ovarian Cancer Statistics

(January 22, 2014) Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer... 

OCRF Research Identifies Biomarker that May Predict Treatment Response

Analisa DiFeo, PhD (January 13, 2014) Researchers at Case Western Reserve University, led by OCRF grantee Analisa DiFeo, PhD have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a finding that has the potential to improve... 

Meet OCRF’s 2014 Grant Recipients

OCRF is pleased to kick off our 20th anniversary with $6.5 million in research grants awarded to 22 scientists at leading medical institutions across the country. The 22 research grants awarded to 17 institutions include 12 new Ann Schreiber Mentored Investigator Awards to bright young ovarian cancer... 

OCRF Research Finds New “Chemoimmunotherapy” May Be New Treatment Option

OCRF Grantee Kunle Odunsi, MD, PhD New research funded by OCRF shows that treatment with the drug decitabine, prior to administration of chemotherapy and a cancer vaccine, yielded clinical benefit for women with recurrent ovarian cancer. This suggests that this combinatorial “chemoimmunotherapy”... 

New Guidelines on Risk, Genetic Counseling & Testing for BRCA-related Cancer

(December 30, 2013)   The U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer in Women. This final recommendation statement applies to women who have no signs or symptoms of... 

High Volume Hospitals and Providers Improve Survival

(December 20, 2013)  Researchers have found that for women with advanced-stage ovarian cancer, being treated at a high volume hospital with a high volume provider, leads to improved survival.  The research was published online today in Gynecologic Oncology. Among patients with advanced-stage ovarian...